Cost-effectiveness of bivalent, quadrivalent, and nonavalent HPV vaccination in South Africa
In South Africa, the prevalence of human papillomavirus (HPV) and associated diseases, such as cervical cancer and genital warts, is among the highest in the world. This study evaluates the cost-effectiveness of bivalent, quadrivalent, and nonavalent HPV vaccination for 9- to 14-year-old girls from...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
16 March 2022
|
| In: |
Clinical drug investigation
Year: 2022, Jahrgang: 42, Heft: 4, Pages: 333-343 |
| ISSN: | 1179-1918 |
| DOI: | 10.1007/s40261-022-01138-6 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s40261-022-01138-6 Verlag, kostenfrei, Volltext: https://link.springer.com/article/10.1007/s40261-022-01138-6 
|
| Verfasserangaben: | Daniel Tobias Michaeli, Sophia Stoycheva, Simon Mashudu Marcus, Wenjia Zhang, Julia Caroline Michaeli, Thomas Michaeli |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1883778336 | ||
| 003 | DE-627 | ||
| 005 | 20240703154808.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240319s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40261-022-01138-6 |2 doi | |
| 035 | |a (DE-627)1883778336 | ||
| 035 | |a (DE-599)KXP1883778336 | ||
| 035 | |a (OCoLC)1443657413 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Michaeli, Daniel |d 1997- |e VerfasserIn |0 (DE-588)1277183244 |0 (DE-627)1830345109 |4 aut | |
| 245 | 1 | 0 | |a Cost-effectiveness of bivalent, quadrivalent, and nonavalent HPV vaccination in South Africa |c Daniel Tobias Michaeli, Sophia Stoycheva, Simon Mashudu Marcus, Wenjia Zhang, Julia Caroline Michaeli, Thomas Michaeli |
| 264 | 1 | |c 16 March 2022 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 19.03.2024 | ||
| 520 | |a In South Africa, the prevalence of human papillomavirus (HPV) and associated diseases, such as cervical cancer and genital warts, is among the highest in the world. This study evaluates the cost-effectiveness of bivalent, quadrivalent, and nonavalent HPV vaccination for 9- to 14-year-old girls from the South African healthcare system perspective. | ||
| 700 | 1 | |a Stoycheva, Sophia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Marcus, Simon Mashudu |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zhang, Wenjia |e VerfasserIn |4 aut | |
| 700 | 1 | |a Michaeli, Julia |d 1996- |e VerfasserIn |0 (DE-588)127911424X |0 (DE-627)1832296377 |4 aut | |
| 700 | 1 | |a Michaeli, Christoph T. |d 1992- |e VerfasserIn |0 (DE-588)1277182337 |0 (DE-627)1830343769 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical drug investigation |d Berlin [u.a.] : Springer, 1989 |g 42(2022), 4 vom: Apr., Seite 333-343 |h Online-Ressource |w (DE-627)327645083 |w (DE-600)2043793-6 |w (DE-576)273880837 |x 1179-1918 |7 nnas |a Cost-effectiveness of bivalent, quadrivalent, and nonavalent HPV vaccination in South Africa |
| 773 | 1 | 8 | |g volume:42 |g year:2022 |g number:4 |g month:04 |g pages:333-343 |g extent:11 |a Cost-effectiveness of bivalent, quadrivalent, and nonavalent HPV vaccination in South Africa |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s40261-022-01138-6 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s40261-022-01138-6 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240319 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 1277182337 |a Michaeli, Christoph T. |m 1277182337:Michaeli, Christoph T. |d 60000 |d 61400 |e 60000PM1277182337 |e 61400PM1277182337 |k 0/60000/ |k 1/60000/61400/ |p 6 |y j | ||
| 998 | |g 127911424X |a Michaeli, Julia |m 127911424X:Michaeli, Julia |d 60000 |e 60000PM127911424X |k 0/60000/ |p 5 | ||
| 998 | |g 1277183244 |a Michaeli, Daniel |m 1277183244:Michaeli, Daniel |d 60000 |e 60000PM1277183244 |k 0/60000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1883778336 |e 4501676817 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"physDesc":[{"extent":"11 S."}],"relHost":[{"language":["eng"],"part":{"volume":"42","pages":"333-343","extent":"11","year":"2022","issue":"4","text":"42(2022), 4 vom: Apr., Seite 333-343"},"disp":"Cost-effectiveness of bivalent, quadrivalent, and nonavalent HPV vaccination in South AfricaClinical drug investigation","physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2043793-6"],"issn":["1179-1918"],"eki":["327645083"]},"recId":"327645083","note":["Gesehen am 23.04.14"],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"publisherPlace":"Berlin [u.a.] ; Auckland","dateIssuedDisp":"1989-","publisher":"Springer ; ADIS International","dateIssuedKey":"1989"}],"pubHistory":["1.1989 -"],"title":[{"title":"Clinical drug investigation","title_sort":"Clinical drug investigation"}]}],"name":{"displayForm":["Daniel Tobias Michaeli, Sophia Stoycheva, Simon Mashudu Marcus, Wenjia Zhang, Julia Caroline Michaeli, Thomas Michaeli"]},"recId":"1883778336","id":{"doi":["10.1007/s40261-022-01138-6"],"eki":["1883778336"]},"note":["Gesehen am 19.03.2024"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"16 March 2022","dateIssuedKey":"2022"}],"person":[{"role":"aut","display":"Michaeli, Daniel","family":"Michaeli","given":"Daniel"},{"display":"Stoycheva, Sophia","family":"Stoycheva","given":"Sophia","role":"aut"},{"display":"Marcus, Simon Mashudu","family":"Marcus","given":"Simon Mashudu","role":"aut"},{"role":"aut","display":"Zhang, Wenjia","given":"Wenjia","family":"Zhang"},{"given":"Julia","family":"Michaeli","display":"Michaeli, Julia","role":"aut"},{"role":"aut","display":"Michaeli, Christoph T.","given":"Christoph T.","family":"Michaeli"}],"title":[{"title":"Cost-effectiveness of bivalent, quadrivalent, and nonavalent HPV vaccination in South Africa","title_sort":"Cost-effectiveness of bivalent, quadrivalent, and nonavalent HPV vaccination in South Africa"}]} | ||
| SRT | |a MICHAELIDACOSTEFFECT1620 | ||